EVP has developed powerful strategic alliances that help us deliver an expanded set of solutions to private and public companies and for venture capital funds.
Our exclusive strategic alliances enable us to deliver world class domain expertise and services in the following three areas:

1. Underperforming or distressed company IP asset sales (Gerbsman Partners)
2. Molecular diagnostics investment banking (Leomics)

3. Drug development services (Davos Pharma)


These alliances have been forged through longstanding relationships with the principals of our strategic partners.  Our network of deep relationships allows us to creatively bring solutions to companies in ways few others can.